http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
배순기(Soon Kie Bae),노임환(Im Hwan Roe),김정택(Jung Taik Kim),서진석(Jin Suk Seo),김학수(Hak Soo Kim) 대한소화기학회 1993 대한소화기학회지 Vol.25 No.5
Retroperitoneal mucinous cystneoplasm was very rare, and the cause and histogenesis of the retroperitoneal location were unclear. We report a case of retroperitoneal mucinous cystadenoma of 64-year-old female. The mass was multilobulated and 17 * 8 * 10 cm in size and filled with oily gray mucous fluid in the right retroperitoneal area. The ovary and appendix were normal
윤용범(Yong Bum Yoon),김정용(Chung Yong Kim),배순기(Soon Kie Bae),김창민(Chang Min Kim),김상준(Sang Joon Kim),지제근(Je Keun Chi) 대한소화기학회 1981 대한소화기학회지 Vol.13 No.2
Pancreatic cystadenocarcinoma is one of the rare malignant tumors, accounting for about 1% of all pancreatic malignancies. The lesion is seen about half as frequently as its benign counterpart; the cystadenoma. It's clinical feature are different from the solid pancreatic neoplasm. There is female predo- minance and it's prognosis is much better than the solid neoplasm of the pancreas. Accurate diagnosis and proper treatment. therefore, are very important to the pancreatic cystadenoarcinoma, However, there's no published report on this neoplasm yet in Korea. We experienced one case of pancreatic cystadenocarcinoma proved by histologic feature recently and report the case with the review of literature
내시경적 (內視鏡的) 역행성 췌담관조영술의 (膵膽管造影術) 합병증에 (合倂症) 대한 Gabexate mesilate ( FOY ) 의 예방적 (豫防的) 효과
송인성(In Sung Song),김정용(Chung Yong Kim),윤영범(Yong Bum Yoon),배순기(Soon Kie Bae),송제일(Je Il Song) 대한소화기학회 1981 대한소화기학회지 Vol.13 No.2
N/A The development and prevalence of endoscopic retrograde cholangiopancreatography(ERCP) has resulted in great progress in the diagnosis of the disease of the pancreas, and biliary tract. At the same time, however, the rise of serum amylase level has been often point out as the complication of ERCP. To assess the effect of synthetic protease inhibitor, Gabexate mesilate(FOY), in hyperamylasemia following ERCP, the authors carried out a controlled trial in 39 patients who were underwent ERCP under the impression of pancreatic or biliary system disease. Of them 20 patients were allocated to FOY@ treated group and 10 patients to control group. The following results were obtained: 1) There was no significant difference in serum amylase level between FOY treated group and control group before ERCP, however significant difference was observed in seram amylase level at 2 hour and 2 day after ERCP between FOY treated group and control group Before ERCP the serum amylase level was 107. 6 45. 1 I.U./dl in control group and 105. 7+-42.1 I.U./dl in FOY treated group.At 2hour after ERCP the serum amylase level was 186.7 +-150.1 I.U./dl in control group and 103.2+-47.9 I.U./dl in FOY treated group. On 2nd day after ERCP, the serum amylase level was 167.7+-84. 1 I.U,/dl in control group and 109.6+-59.1 I.U./dl in FOY treated group 2) The change in serum amylase levels at 2 hour and 2 day after ERCP by the extent of visualization showed a tendency that a greater extent of visualization was associated with a higher incidence of serum amylase levels. Such a tendency was more pronounced in control group and the mean serum amylase level was significantly higher in the control group. 3) FOY did not cause any serious side effect such as shock, fall of blood pressure, itching, eruption, chest pain etc. in all cases. 4) There was some report that FOY has a relaxant action on the Oddis sphincter and helps the cannulation to the opening of Papilla of Vater, however it more depended upon the skill of the endoscopist, anatomical variation of the Papilla of Vater and FOY did not give any great advantage to the cannulation.